Ventyx Biosciences Inc.

1.45
-0.13 (-8.23%)
At close: Mar 03, 2025, 3:59 PM
1.46
0.69%
After-hours: Mar 03, 2025, 04:08 PM EST

Ventyx Biosciences Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 27.26M 51.58M 64.82M 70.79M 244K 309K
Short-Term Investments 190.06M 200.64M 253.12M 187.78M n/a n/a
Long-Term Investments n/a n/a 38.67M 28.15M n/a n/a
Other Long-Term Assets 36.66M 1.08M 96K 60K n/a n/a
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 12.3M 12.13M 12.75M 4.44M 1K 40K
Total Current Assets 229.63M 264.35M 330.69M 263.02M 245K 349K
Property-Plant & Equipment 10.28M 12.27M 1.94M 254K n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 46.94M 13.35M 40.71M 28.46M n/a n/a
Total Assets 276.56M 277.69M 371.4M 291.48M 245K 349K
Account Payables 3.13M 5.76M 6.43M 4.66M 1.1M 362K
Deferred Revenue n/a n/a n/a n/a n/a n/a
Short-Term Debt 1.05M 1M 824K n/a n/a n/a
Other Current Liabilities 8.59M 15.51M 9.1M 7.62M 301K 269K
Total Current Liabilities 12.78M 22.27M 16.36M 12.28M 1.4M 631K
Long-Term Debt 9.74M 11.51M 1.15M n/a 12.65M 3.85M
Other Long-Term Liabilities n/a n/a n/a n/a 16.85M n/a
Total Long-Term Liabilities 9.74M 11.51M 1.15M n/a 29.5M 3.85M
Total Liabilities 22.52M 33.77M 17.5M 12.28M 30.9M 4.48M
Total Debt 10.79M 12.51M 1.56M n/a 12.65M 3.85M
Common Stock 7K 6K 6K 5K n/a n/a
Retained Earnings -554.31M -419.19M -226.22M -117.8M -32.5M -4.33M
Comprehensive Income 157K -50K -1.12M -58K n/a n/a
Shareholders Equity 254.04M 243.92M -226.22M -117.8M -30.65M -4.13M
Total Investments 190.06M 200.64M 291.79M 215.93M n/a n/a